SLC18A2

gene product
SVAT, SVMT, VMAT2
The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (summary by Peter et al., 1993 [PubMed 7905859]). See also SLC18A1 (MIM 193002). [supplied by OMIM, Jan 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
209 antibodies from 27 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
OriGene
5 antibodies
Novus Biologicals
25 antibodies
GeneTex
4 antibodies
antibodies-online
55 antibodies
R&D Systems
1 antibody
LifeSpan BioSciences, Inc.
28 antibodies
Acris Antibodies GmbH
5 antibodies
Biorbyt
6 antibodies
Everest Biotech
1 antibody
Aviva Systems Biology
3 antibodies
Arigo
2 antibodies
Atlas Antibodies
1 antibody
Bioworld Technology, Inc
1 antibody
NSJ Bioreagents
1 antibody
Abnova Corporation
2 antibodies
Proteintech Group
1 antibody
Creative Biolabs
6 antibodies
MyBioSource
8 antibodies
Rockland Immunochemicals, Inc.
1 antibody
Abgent
2 antibodies
EMD Millipore
1 antibody
United States Biological
36 antibodies
Sigma-Aldrich
4 antibodies
St John's Laboratory
1 antibody
Creative Diagnostics
4 antibodies
PhosphoSolutions
1 antibody
Invitrogen Antibodies
4 antibodies